p‐cymene impairs SARS‐CoV‐2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS‐CoV‐2 nucleocapsid protein and H1N1 nucleoprotein

• Main Authors: Athanasios Panagiotopoulos (Author), Melpomeni Tseliou (Author), Ioannis Karakasiliotis (Author), Danai‐Maria Kotzampasi (Author), Vangelis Daskalakis (Author), Nikolaos Kesesidis (Author), George Notas (Author), Christos Lionis (Author), Marilena Kampa (Author), Stergios Pirintsos (Author), George Sourvinos (Author), Elias Castanas (Author)
• Format: Book
• Published: Wiley, 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Therapeutic regimens for the COVID‐19 pandemics remain unmet. In this line, repurposing of existing drugs against known or predicted SARS‐CoV‐2 protein actions have been advanced, while natural products have also been tested. Here, we propose that p‐cymene, a natural monoterpene, can act as...